MARKET

DHR

DHR

Danaher Corporation
NYSE

Real-time Quotes | Nasdaq Last Sale

258.05
+4.53
+1.79%
After Hours: 257.34 -0.71 -0.28% 19:35 07/01 EDT
OPEN
254.37
PREV CLOSE
253.52
HIGH
258.74
LOW
251.05
VOLUME
1.40M
TURNOVER
0
52 WEEK HIGH
333.96
52 WEEK LOW
233.47
MARKET CAP
187.62B
P/E (TTM)
30.29
1D
5D
1M
3M
1Y
5Y
Danaher (DHR) Stock Moves -1.77%: What You Should Know
In the latest trading session, Danaher (DHR) closed at $251.88, marking a -1.77% move from the previous day.
Zacks · 3d ago
Here's How Much $100 Invested In Danaher 20 Years Ago Would Be Worth Today
Danaher (NYSE:DHR) has outperformed the market over the past 20 years by 7.67% on an annualized basis producing an average annual return of 14.78%. Currently, Danaher has a market capitalization of $186.88 billion.
Benzinga · 4d ago
The Zacks Analyst Blog Highlights Tesla, Broadcom, Anthem, Oracle and Danaher
Tesla, Broadcom, Anthem, Oracle and Danaher have been included in this Analyst Blog.
Zacks · 06/24 09:30
Top Stock Reports for Tesla, Broadcom & Anthem
Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Broadcom Inc. (AVGO), and Anthem, Inc. (ANTM).
Zacks · 06/23 15:47
Danaher (DHR) Exhibits Bright Prospects, Headwinds Persist
Danaher (DHR) gains from solid demand for its products, acquired assets and shareholder-friendly policies. However, escalating costs and high debt levels remain concerns.
Zacks · 06/23 12:59
Danaher (DHR) Gains As Market Dips: What You Should Know
Danaher (DHR) closed at $245.91 in the latest trading session, marking a +0.84% move from the prior day.
Zacks · 06/22 21:50
Danaher Schedules Second Quarter 2022 Earnings Conference Call
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2022 on Thursday, July 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour.
PR Newswire · 06/21 20:30
A '70s style recession would push S&P 500 to 2,525 - SocGen
A recession is 74% priced into stocks and there is a remote chance economic conditions could push the S&P 500 (SP500) (NYSEARCA:SPY) more than 1,000 points lower, Societe Generale says.
Seekingalpha · 06/21 14:45
More
No Data
Learn about the latest financial forecast of DHR. Analyze the recent business situations of Danaher Corporation through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 23 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

30.43%Strong Buy
56.52%Buy
13.04%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average DHR stock price target is 328.41 with a high estimate of 363.40 and a low estimate of 265.00.
High363.40
Average328.41
Low265.00
Current 258.05
EPS
Actual
Estimate
0.691.382.072.76
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 2.49K
Institutional Holdings: 629.82M
% Owned: 86.62%
Shares Outstanding: 727.08M
TypeInstitutionsShares
Increased
784
25.41M
New
114
1.15M
Decreased
793
23.97M
Sold Out
147
2.13M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.68%
Healthcare Equipment & Supplies
+1.92%
Key Executives
Chairman/Director
Steven Rales
President/Chief Executive Officer/Director
Rainer Blair
Co-Founder/Director
Mitchell Rales
Chief Financial Officer/Executive Vice President
Matthew McGrew
Executive Vice President
Jennifer Honeycutt
Executive Vice President
Joakim Weidemanis
Senior Vice President/Chief Scientific Officer
Jose-Carlos Gutierrez-Ramos
Senior Vice President/General Counsel
Brian Ellis
Senior Vice President
Georgeann Couchara
Senior Vice President
William King
Senior Vice President
Daniel Raskas
Lead Director/Independent Director
Linda Hefner Filler
Independent Director
Feroz Dewan
Independent Director
Teri List-Stoll
Independent Director
Walter Lohr
Independent Director
Jessica Mega
Independent Director
Pardis Sabeti
Independent Director
A. Shane Sanders
Independent Director
John Schwieters
Independent Director
Alan Spoon
Independent Director
Raymond Stevens
Independent Director
Elias Zerhouni
No Data
No Data
About DHR
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.

Webull offers kinds of Danaher Corporation stock information, including NYSE:DHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DHR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DHR stock methods without spending real money on the virtual paper trading platform.